Clinical Trial Update: Safety Evaluation of a Q-fever Vaccine, NDBR 105 [Phase 2]

View source ↗

Summary

Phase 2 safety evaluation completed for a Q fever vaccine (NDBR 105) with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fever

Drugs mentioned

• NDBR 105

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Q Fever | Phase 2 | Status: COMPLETED | Results posted: 2017-03-09